Breast Cancer Biomarker May Predict Recurrence After Tamoxifen

cp418

http://www.medicalnewstoday.com/articles/262713.php

Some women treated for ER-positive breast cancer are at higher risk for recurrence after completing tamoxifen treatment. Now a new US study suggests that by measuring a genetic biomarker, it may be possible to predict which women will have this higher risk, thus sparing a lot of women from treatment they don't need.

(I've noticed with many articles referring to early stage breast cancer they imply node negative which eliminates stage 2 patients.)

jenrio

Its twin study for letrozol is here:

http://community.breastcancer.org/forum/73/topic/806969

Quite a beauty contest.

Thanks cp.  Keep doing good work researching.